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Abstract
Background: The objective of this study was to determine whether neonatal nasogastric enteral feeding tubes
are colonised by the opportunistic pathogen Cronobacter spp. (Enterobacter sakazakii) and other Enterobacteriaceae,
and whether their presence was influenced by the feeding regime.
Methods: One hundred and twenty-nine tubes were collected from two neonatal intensive care units (NICU).
A questionnaire on feeding regime was completed with each sample. Enterobacteriaceae present in the tubes were
identified using conventional and molecular methods, and their antibiograms determined.
Results: The neonates were fed breast milk (16%), fortified breast milk (28%), ready to feed formula (20%),
reconstituted powdered infant formula (PIF, 6%), or a mixture of these (21%). Eight percent of tubes were
received from neonates who were 'nil by mouth'. Organisms were isolated from 76% of enteral feeding tubes as
a biofilm (up to 107 cfu/tube from neonates fed fortified breast milk and reconstituted PIF) and in the residual
lumen liquid (up to 107 Enterobacteriaceae cfu/ml, average volume 250 μl). The most common isolates were
Enterobacter cancerogenus (41%), Serratia marcescens (36%), E. hormaechei (33%), Escherichia coli (29%), Klebsiella
pneumoniae (25%), Raoultella terrigena (10%), and S. liquefaciens (12%). Other organisms isolated included C.
sakazakii (2%),Yersinia enterocolitica (1%),Citrobacter freundii (1%), E. vulneris (1%), Pseudomonas fluorescens (1%), and
P. luteola (1%). The enteral feeding tubes were in place between < 6 h (22%) to > 48 h (13%). All the S. marcescens
isolates from the enteral feeding tubes were resistant to amoxicillin and co-amoxiclav. Of additional importance
was that a quarter of E. hormaechei isolates were resistant to the 3rd generation cephalosporins ceftazidime and
cefotaxime. During the period of the study, K. pneumoniae and S. marcescens caused infections in the two NICUs.
Conclusion: This study shows that neonatal enteral feeding tubes, irrespective of feeding regime, act as loci for
the bacterial attachment and multiplication of numerous opportunistic pathogens within the Enterobacteriaceae
family. Subsequently, these organisms will enter the stomach as a bolus with each feed. Therefore, enteral feeding
tubes are an important risk factor to consider with respect to neonatal infections.
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Background
Recently, considerable attention has been directed at the
microbiological safety of PIF [1,2]. This has primarily
been due neonatal infections by C. sakazakii and Salmo-
nella, which were associated with contaminated PIF [3-6].
These products are not sterile, but are expected to comply
with international microbiological standards [7]. Other
Enterobacteriaceae  which have been isolated from PIF
include Enterobacter cloacae, Klebsiella pneumoniae, K. oxy-
toca, E. hormaechei,Citrobacter freundii, and E. coli [8,9].
The FAO/WHO [1,2] categorised these organisms as 'cau-
sality plausible, but not yet demonstrated' with respect to their
potential to cause neonatal illness through the ingestion
of reconstituted PIF. Although these organisms are oppor-
tunistic pathogens, there have been no confirmed out-
breaks in NICUs attributed to their presence in
contaminated PIF. This in part may be related to misiden-
tification and delays in investigation. For example, rein-
vestigation of a C. sakazakii outbreak on a NICU revealed
the organisms were E. hormaechei [9]. In another NICU
outbreak, the powdered infant formula was not analysed
until after the last neonatal case and the original batch of
infant formula would no longer have been available [3].
The FAO/WHO [1] proposed that the risk of bacterial
infection from powdered infant formula could be reduced
by reconstitution with water > 70°C, minimising the time
between reconstitution and feeding (< 2 h), and by not
storing reconstituted feed at ambient temperature. These
recommendations are reiterated by WHO [10], and vari-
ous regulatory bodies [11-13]. However, there was no
consideration that the nasogastric enteral feeding tube
may act as a site for bacterial colonisation as a biofilm.
The tube will be between ambient (outer portion) and
body temperature (inner portion), with regular additions
of nutrients from the infant feed and in-place over suffi-
cient time periods for bacterial multiplication. Previously,
nasogastric feeding tubes in a nursing home have been
shown to be a reservoir for E. coli and  Klebsiella  with
extended spectrum β-lactamases (ESBL) [14]. Berthelot et
al. [15] proposed a role of enteral feeding in the colonisa-
tion and infection of premature infants by K. oxytoca. In
recent years there has been a rise in incidence of neonatal
infections due to Enterobacteriaceae, and they are the pre-
dominant causative agents in NICU outbreaks [16-18].
Klebsiella spp. infections outnumber staphylococci infec-
tions, and Serratia spp. are the third most common causa-
tive pathogen [16]. Pathogenic strains of E. coli are one of
the leading causes of neonatal meningitis and sepsis [19].
Neonates may be particularly prone to Gram negative
infections as their innate immune cells have low
responses to lipopolysaccharide (part of the Gram nega-
tive cell wall structure) and macrophage response [20].
Prior to weaning, the infant intestinal flora is influenced
by the feeding regime [21]. The initial intestinal flora of
infants who are breast fed are dominated by lactic acid
bacteria and bifidobacteria, whereas the intestinal flora of
formula fed infants is more diverse and dominated by the
Enterobacteriaceae and Bacteroides spp. [22]. However, this
is a generalisation, as in practice neonates may receive a
mixed nutrient source regime for short periods according
to their nutritional needs. This may include the use of
thickeners to reduce reflux, and these details may not be
sufficiently recorded for later analysis. Few studies have
considered the neonatal nasogastric enteral feeding tube
in NICUs acting as a site of bacterial colonisation, and any
influence of the feeding regime. Mehall et al. [23] detected
Staphylococcus epidermidis, S. aureus, Enterococcus faecalis, E.
cloacae  and  K. pneumoniae at > 103 cfu/ml in 71/125
enteral tubes from infants > 4 months, and that necrotiz-
ing enterocolitis developed in 7 formula fed infants with
tubes containing > 105 Gram negative bacteria/ml. This
group also reported the isolation of methicillin-resistant
S. aureus from infant enteral feeding tubes [24]. Therefore
collating information on hospital feeding regimes, and
microbial analysis of feeding tubes will considerably
improve our knowledge and understanding of potential
risk factors to neonates linked to enteral feeding. This
study is important to identify locations of bacterial multi-
plication which might be of risk to neonates, especially in
NICUs.
Results
Neonate feeding regime
A total of 129 nasogastric enteral feeding tubes were col-
lected from two NICUs; 25 and 104 respectively. The
neonates' age range was from < 1 wk to greater than 4 wk,
with the major group (42%) being > 4 wk (See additional
file 1). Four specific feeding regimes were identified;
'breast milk', 'fortified breast milk', 'ready to feed for-
mula', and 'reconstituted PIF'. Additionally, a number of
neonates were receiving more than one type of feed. These
are described as receiving a 'mixed feeding regime'. This
latter category is a heterogeneous population. For exam-
ple, some neonates received breast milk and fortified
breast milk, whereas others received breast milk and
reconstituted PIF. A thickener was added to feeds to
reduce reflux for neonates receiving fortified breast milk,
ready to feed formula, reconstituted PIF, and mixed feed.
Ten tubes were received from neonates that were 'nil by
mouth' (see additional file 1). The frequency of feeding
was primarily every 2 h for breast milk, whereas there were
equal numbers of every 2 h and 3 h for those receiving
ready to feed formula (see additional file 1). Eight
neonates were fed ready to feed formula, reconstituted
PIF, and mixed feed continuously. The enteral feeding
tubes had been in place for various time periods; ranging
from < 6 h (22%) to > 48 h (13%) (see additional file 1).
The gastric pH was measured prior to feeding, and was
between 1.5 and 6. The average pH ranged from 2.5 to 4.3
for breast milk and reconstituted PIF fed neonates, respec-
tively (see additional file 1).BMC Infectious Diseases 2009, 9:146 http://www.biomedcentral.com/1471-2334/9/146
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Microbiological analysis of enteral feeding tubes
Bacterial counts on tubes
Enterobacteriaceae were isolated from the majority (76%)
of samples, and from all feeding regimes (see additional
file 2). The lowest frequency of isolation was 52% of the
tubes from breast milk fed neonates, whereas the others
ranged from 78 to 88% for mixed feeding regime and
reconstituted PIF (see additional file 2).
The dataset for NICU 2 (n = 104) was chosen for detailed
statistical analysis due to the larger number of samples,
and the 'nil by mouth' cohort was regarded as a control
group for the feeding regimes. Feeding regime had a sig-
nificant effect on the Enterobacteriaceae counts (F = 3.90, P
< 0.001). The lowest values obtained were 'nil by mouth'
and 'breast milk' only with an average values ca. 1.4 log10
cfu/tube (Fig. 1). The maximum 'nil by mouth' was 2.7
log10 cfu/tube which was less than the average for the
remaining groups. The maximum for the breast milk
cohort was 5.3 log10 cfu/tube. This value was considerable
higher than the other neonates in the cohort, and could
have been influenced by the exceptionally high pH (6.0)
of this one sample. Fischer's protected least significant dif-
ference post-hoc tests suggested that 'fortified breast milk',
'ready to feed formula', 'reconstituted PIF' and 'mixed for-
mula' all gave significantly greater counts than 'nil by
mouth' regime. Hence, 'breast milk' and 'ready to feed'
gave bacterial counts similar to those on the 'nil by
mouth' regime. Statistical analysis showed that although
there was a significant number of younger babies (< 1 wk)
in this group, there was no statistical significant difference
in colonisation between age groups (Analysis of variance
1-way F = 0.99, P > 0.05). Similarly, within the fortified
breast milk group there was no significant effect of age on
colonisation (Analysis of variance 1-way F = 0.89, P >
0.050). Hence, although there were some differences in
age profiles within treatment groups and an overall effect
of age, there was no evidence from our data that age effects
colonization within a feeding group. It is accepted that the
numbers within each group are small for these compari-
sons and it is possible that there were confounding prob-
lems of age with feeding regime. Within the mixed feeding
regime group, analysis of the various feeding regimes sug-
gested that those fed with breast milk and fortified breast
milk, and PIF and breast milk, gave significantly higher
counts than nil by mouth (F = 3.19, P < 0.05), but not the
ready to feed formula and breast milk group. There was no
difference in bacterial counts when a thickener was added
to the feed.
The effect of age of the infant on mean bacterial counts is
shown in Fig. 2. There was a significant effect of age on
bacterial counts when data were pooled (F = 4.49, P <
0.001) indicating a progressive increase in numbers with
increasing age from 2 wk onwards. There was a significant
effect of length of time the tube was in place when data
were pooled (F = 6.91, P < 0.001). Compared with data at
< 6 h, those at 6-12 h, 18- < 24 h, 24-48 h, and > 48 h, all
had significantly greater bacterial counts, with maximum
counts recorded at 48 h. When data are pooled, there was
a positive but weak correlation between Enterobacteriaceae
numbers and pH (r = 0.24, P < 0.05). However r2 suggests
only 5.8% of the variance in bacterial numbers can be
Enterobacteriaceae counts from biofilm material isolated from  nasogastric enteral feeding tubes of neonates on various  feeding regimes Figure 1
Enterobacteriaceae counts from biofilm material iso-
lated from nasogastric enteral feeding tubes of 
neonates on various feeding regimes. Error bars indi-
cate 95% confidence intervals. NBM = Nil by mouth (n = 10). 
BMO = Breast milk only (n = 17), FBM = fortified breast milk 
(n = 27), RFF = ready to feed formula (n = 21), PIF = Pow-
dered infant formula (n = 8), M = mixed feeding regime 
(n = 20).
Enterobacteriaceae counts from biofilm material on nasogas- tric enteral feeding tube according to age of neonate Figure 2
Enterobacteriaceae counts from biofilm material on 
nasogastric enteral feeding tube according to age of 
neonate. Error bars indicate 95% confidence intervals.BMC Infectious Diseases 2009, 9:146 http://www.biomedcentral.com/1471-2334/9/146
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accounted for by pH. A one-way Anova comparing pH
with age showed there was no significant difference in
average pH between infant age classes. There were no sig-
nificant effects of age within the 'nil by mouth' group
(Analysis of variance 1-way F = 10.00 P > 0.05).
Bacterial counts in residual liquids
During laboratory analysis of the feeding tubes, it was
noted that there was residual liquid present. The average
volume of residual liquid was 250 μl, and ranged between
30 and 400 μl. The average viable count was 107 cfu/ml,
and ranged between < 102 to 108 cfu/ml. Therefore, the
number of Enterobacteriaceae present in the residual liquid
per tube was up to 107 cfu. This is the potential number of
Enterobacteriaceae that would have entered the neonatal
stomach with the next feed, if the tube had not been
removed.
Bacterial species on tubes and in the residual liquids
The same Enterobacteriaceae  species were isolated from
both the residual liquids and the biofilms. The Enterobac-
teriaceae isolated were primarily E. cancerogenus (41%), S.
marcescens (36%), E. hormaechei (33%), E. coli (29%), K.
pneumoniae (25%), and R. terrigena (22%) (see additional
file 2). Other organisms isolated less frequently included
C. sakazakii from breast milk and ready to feed formula
groups, and a single isolate of Y. enterocolitica from the
reconstituted PIF group. E. cancerogenus, S. marcescens, and
E. hormaechei and were isolated from all feeding regimes,
including the 'nil by mouth' cohort (see additional file 2).
The E. hormaechei and E. cancerogenus (identified by16S
rDNA sequence analysis) were presumptively identified as
E. cloaceae and K. oxytoca, respectively, by phenotypic pro-
filing. Non-Enterobacteriaceae  which were isolated from
VRBGA included P. fluorescens, P. luteola and Chromobacte-
rium violaceum. Electron microscopy of enteral feeding
tube inner wall revealed that a dense, and morphologi-
cally diverse flora was present (Fig 3 and 4). This included
a variety of short and long rod-shaped bacteria; some with
tapering ends (Fig. 3). Yeast size cells were also visible
(Fig. 4). Preliminary experiments with direct plating of
enteral tube material on non-selective agar isolated sta-
phylococci, lactic acid bacteria and Candida albicans (data
not shown). Since these were not the focus of the study,
they were not investigated further. There was no signifi-
cant difference in the proportion of samples positive for
Enterobacteriaceae  between the feeding regimes (chi-
square = 7.82, 5DF, P > 0.05). The distribution of bacterial
species was different in tubes from 'nil by mouth' samples
compared with all other regimes added together (chi-
square = 16.28, 7DF P < 0.05). After removing the 'nil by
mouth' samples from the statistical analysis, there were
highly significant differences in the distribution of isolates
between feeding regimes (chi-square = 94.95, 28DF, P <
0.001). Comparing each feeding regime with each of the
others, showed that the breast milk and mixed feeding
regimes were the only two giving similar distribution of
isolates (chi-square = 9.72, 7DF, P > 0.05). Each of the
other feeding regimes has a unique distribution of bacte-
rial isolates.
Antibiotic resistance of isolated Enterobacteriaceae
All  Enterobacteriaceae  isolates were susceptible to gen-
tamicin, ciprofloxacin and meropenem. The majority of
Electron microscopy of enteral feeding tube inner wall from  neonate fed breast milk and ready to feed formula Figure 3
Electron microscopy of enteral feeding tube inner 
wall from neonate fed breast milk and ready to feed 
formula. Bar indicates 4 μm size marker.
Electron microscopy of enteral feeding tube inner wall from  neonate fed breast milk and reconstituted PIF with added  thickener Figure 4
Electron microscopy of enteral feeding tube inner 
wall from neonate fed breast milk and reconstituted 
PIF with added thickener. Bar indicates 10 μm size 
marker.BMC Infectious Diseases 2009, 9:146 http://www.biomedcentral.com/1471-2334/9/146
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strains were resistant to amoxicillin. The antibiograms for
the remaining antibiotics are summarised in additional
file 3. All S. marcescens isolates were resistant to amoxicil-
lin and amoxicillin-clavulanic acid. Of note is the high fre-
quency of resistance to ceftazidime (21% strains) and
cefotaxime (23% strains) in E. hormaechei. Three of these
strains contained ESBL. Four of the 37 E. coli strains were
also resistant to ceftazidime and cefotaxime.
Discussion and Conclusion
In this study, a total of 129 nasogastric enteral feeding
tubes with details of the neonates' feeding regime were
obtained from 2 NICUs. The neonates were receiving a
variety of feeds including expressed breast milk, reconsti-
tuted PIF, and sterile ready to feed formula. In addition
tubes were received from infants that were 'nil by mouth'.
The ages of the neonates varied with the feeding regime.
Those on breast milk were predominantly < 1 wk, whereas
those on fortified breast milk were > 4 wk (see additional
file 1). Neonates receiving ready to feed formula were 1 to
> 4 wk in age, whereas the majority of those on reconsti-
tuted powdered infant formula were > 4 wk in age. The
frequency of feeding was primarily (54%) every 2 h, espe-
cially for those on breast milk, and secondly (24%) every
3 h. Eight neonates (6%) were fed continuously. This later
practise is prone to temperature abuse, and has been
linked with outbreaks of C. sakazakii in USA and France
[3,25].
Enterobacteriaceae were isolated from the lumen and the
inner wall of most (75%) enteral feeding tubes; see addi-
tional file 2. The organisms were initially identified using
biochemical profiles and thereafter 16S rDNA sequence
analysis as the later is more accurate [9,26]. The Enterobac-
teriaceae isolated were primarily E. coli, E. cancerogenus, E.
hormaechei, K. pneumoniae, R. terrigena, and S. marcescens.
These are well recognised opportunistic pathogens caus-
ing various gastrointestinal and respiratory diseases.
Other organisms isolated included C. sakazakii, Y. entero-
colitica, E. vulneris, and Pseudomonas spp. There were some
differences in the flora between the feeding regimes, the
reasons for which are currently unclear. The flora isolated
from our neonatal samples is similar to that of Mehall et
al. [24] who reported the isolation of E. cloacae, K. pneu-
moniae, S. maltophila and P. aeruginosa from enteral tubes
of infants aged > 4 months. Other organisms present
included Gram positive organisms such as staphylococci,
and lactic acid bacteria, as well as Candida albicans. This
fungus was also isolated in the study by Mehall et al. [24].
The antibiograms for the Enterobacteriaceae isolated are
shown in additional file 3. Trimethoprim, ampicillin and
co-amoxiclav are commonly used for minor infections in
adults. Piptazobactam, amikacin, ceftazidime and cefo-
taxime are antibiotics that could be prescribed for empir-
ical treatment of serious sepsis in infants on a neonatal
intensive care unit. Of note is the high frequency of resist-
ance by the E. hormaechei to the 3rd generation cepha-
losporins ceftazidime and cefotaxime. ESBL were detected
in 3 of these strains. The antibiotic resistance patterns of
the remaining strains could be due to derepressed chro-
mosomal AMPC β-lactamase production [27]. As already
proposed [28], it is plausible that the empiric use of anti-
microbial agents selects for clones of EBSL organisms such
as S. marcescens and K. pneumoniae. Although no link was
established with feeding tube isolates, it is notable that
these two species were also responsible for neonatal infec-
tions in both NICUs during our study. Resistance to these
antibiotics would not be recognised until 24 - 48 h of cul-
turing for the causative agent, during which time an inef-
fective antibiotic may have been used to treat the ill
neonate. This delay in effective treatment could have seri-
ous consequences.
The 'nil by mouth' samples received during the study were
treated as negative controls for the feeding regime com-
parison. They demonstrated that sterilisation of the outer
tube surface effectively removed any oral-pharynx flora
contamination. Therefore the organisms detected were
deemed to originate from the inside of the enteral feed
tube. It is probable that the few organisms isolated from
these tubes originated from the throat by tracking along
the outside of the tube into the stomach, or were residual
organisms from before feeding stopped. Due to respect for
strict patient confidentiality, all neonates were anony-
mous and hence we have no knowledge regarding the
feeding regime of neonates prior to the sampling period.
This unfortunately restricts our interpretation of data
obtained for neonates that were 'nil by mouth' at the time
of sample collection. Nevertheless, only low numbers of
Enterobacteriaceae (< 3 log10 cfu/tube) were recovered from
these samples (Fig. 1).
The Enterobacteriaceae were isolated from biofilms inside
enteral feeding tubes of neonates who received only breast
milk, but the numbers were lower than other feeding
regimes (Fig. 1). Breast milk is not sterile, but does con-
tain antibacterial agents such as maternal antibodies,
lactoferrin, and lysozyme. Additionally the standard prac-
tice at the 2 NICUs was for expressed breast milk to be
kept at 2-4°C for no more than 48 h and therefore very lit-
tle bacterial growth could have occurred prior to feeding.
Feeding tubes from neonates being fed fortified breast
milk contained higher numbers of Enterobacteriaceae than
unfortified breast milk; 3.6 log10 cfu/tube compared with
1.4 log10 cfu/tube respectively (Fig. 1). Human milk forti-
fiers may enable bacterial growth by providing free iron
which is otherwise unavailable due to chelation in unfor-
tified breast milk [29]. Another factor which may have
affected the bacterial counts is that neonates fed fortifiedBMC Infectious Diseases 2009, 9:146 http://www.biomedcentral.com/1471-2334/9/146
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breast milk were older than those fed breast milk (see
additional file 1). Some of the enteral tube flora could
have been due to reflux of small intestinal contents into
the stomach. Since older neonates will have a more estab-
lished intestinal flora, increased bacterial numbers would
be recovered from enteral tubes in the stomach. The 37
fortified breast milk tube samples were treated as one
cohort since to our knowledge only one source of human
milk fortifier was in use.
An unexpected result was the recovery of Enterobacte-
riaceae  biofilms in enteral feeding tubes from 81% of
neonates receiving sterile ready to feed formula. These
products are sterilised inside glass jars by the manufac-
turer and have tamper-proof lids which would indicate
any bacterial growth before use. These feeds were used
directly from the sterile jar, and were not kept open for
any length of time at temperatures enabling bacteria from
extrinsic contamination to multiply. An alternative source
of the enteral tube flora was the throat due to gastro-
esophageal reflux. This is common in preterm neonates,
occurring 3-5 times per hour [30,31]. It occurs when the
lower oesophageal sphincter relaxes, and this may
increase the exposure of the feeding tube to the throat
flora.
The highest Enterobacteriaceae  biofilm levels were from
enteral feeding tubes of neonates receiving reconstituted
PIF; average 4.2 log10 cfu/tube. We have no knowledge
regarding the range of PIF products being used on the
wards, but it is reasonable to assume that various products
had been prescribed by the neonatologists. However
requesting further nutritional information was not per-
missible with respect to patient confidentiality. Therefore
all neonates receiving reconstituted PIF were considered
as one cohort. The same Enterobacteriaceae species were
isolated as per other feeding regimes; E. coli, E. canceroge-
nus, R. terrigena, and S. liquifaciens; see additional file 2.
Other Enterobacteriaceae isolated were Y. enterocolitica, K.
ozaena and C. violaceum. Whether these Enterobacteriaceae
originated from the powdered formula or reflux from the
gastrointestinal tract is uncertain as no bacteriological
analysis of the powdered formula was undertaken. Never-
theless the PIF were reconstituted at room temperature
and therefore were not subject to hot water (> 70°C) to
reduce the number of any intrinsic bacteria as recom-
mended by the FAO/WHO [1,2]. Since, unlike human
breast milk, there are no antibacterial agents in PIF any
contaminating bacteria would be able to multiply in the
formula while the tube was in place for up to 48 h.
As the bacterial biofilms age, the Enterobacteriaceae will
break off in clumps. These clumps will inoculate any fresh
feed in the tube lumen leading to further bacterial multi-
plication, and will subsequently enter the neonate stom-
ach. Although the adult stomach is normally highly
acidic, and kills the majority of ingested bacteria, this is
not true for the neonate. The gastric pH was 2.5 (breast
milk) and 3.5 to 4.3 for the remaining feeding regimes;
see additional file 1. Edelson-Mammel et al. [32] have
shown the acid-sensitivity of C. sakazakii. In their study of
12 strains, the viability decreased by 1 - 3.5 log cycles at
pH 3.5 over a 5 h period. Koutsoumanis and Sofos [33]
reported that the viable counts of E. coli O157:H7, Listeria
monocytogenes, and Salmonella Typhimurium decreased by
2, 4 and 7 log cycles respectively when subjected to the
same conditions. It is plausible that gastric juices were
sometimes present in the enteral feeding tube which
could reduce the biofilm formation. This may account for
the absence of Enterobacteriaceae in tubes from neonates in
which the pH was as low as 1.5 (see additional file 1).
Although C. sakazakii is well known for its association
with infections of low-birth weight, preterm babies
through contaminated PIF, in this study it was isolated
from the enteral feeding tubes of two neonates receiving
breast milk and ready to feed formula, respectively. C.
sakazakii was the sole isolate from the breast milk tube,
and was co-isolated with E. cancerogenus from the ready to
feed formula tube. It should be noted that previously a C.
sakazakii  neonatal infection has been associated with
breast milk [34]. Clinical isolates of Cronobacter can also
produce profuse capsular material which may contribute
to biofilm formation [3]. Non-Enterobacteriaceae isolated
included P. fluorescens and P. luteola; see additional file 2.
These organisms are well known for their ability to form
biofilms which could entrap other organisms less able to
colonise the tubing wall. Therefore their presence may
enhance multiorganism biofilm formation.
The average Enterobacteriaceae count in the tube lumen
was 107 cfu/ml, and the average residual liquid volume
was 250 μl. Therefore, the number of Enterobacteriaceae
present in the lumen was in the range from 102 to 107 cfu.
This equates to the number of Enterobacteriaceae  that
would have entered the neonatal stomach with the next
feed. The organisms probably originate from the attached
bacterial biofilm, and therefore a reduction in biofilm for-
mation should lead to lower numbers of organisms
ingested via the lumen contents. The presence of the resid-
ual liquid was independent of the feeding regime, and
reflected general feeding practices. The presence of the liq-
uid was unexpected as normal practice is to flush the tube
after feeding with a small volume of air or water to clear
it. This residual liquid is a potential risk factor for neona-
tal infection that could be reduced by changing feeding
practices in the NICU. There was limited opportunity for
bacterial multiplication in the feed at room temperature
during the feeding period (< 30 min) compared with the
tube at 37°C which can be in place for > 48 h (see addi-BMC Infectious Diseases 2009, 9:146 http://www.biomedcentral.com/1471-2334/9/146
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tional file 1). Therefore the enteral feeding tube could be
a very important source of bacteria entering neonates, and
would act as a significant amplifying step for opportunis-
tic intestinal pathogens. These organisms would have
entered the stomach as a bolus with the enhanced acid tol-
erance enabling them to survive the gastric acid and sub-
sequently greater potential to colonise and infect the
neonate.
The microbiological safety of neonatal feeds should not
be exclusively focussed on reconstituted PIF due to C.
sakazakii, but also on the general preparation and prac-
tices of enteral feeding to reduce the risk of exposure to
other Enterobacteriaceae some of which may carry antibi-
otic resistance factors. Therefore, the practice of prolonged
placement of enteral feeding tubes in neonates needs to
be considered with respect to the increased risk of expo-
sure to bacterial pathogens.
Methods
Preparation and administration of neonatal feeds
Powdered infant formula was reconstituted with sterile
cold water at room temperature in a sterile bottle. Ready
to feed formula was kept in the original bottle. Expressed
breast milk (EBM) was obtained using a sterile expressing
kit into sterile plastic pots. Fresh EBM was kept for up to
48 hours in a dedicated fridge at 2-4°C. Any EBM which
was not to be used as fresh was frozen for up to 3 months
in a dedicated freezer at -20°C. When required EBM was
defrosted in the fridge and kept for up to 12 hours after
removal from the freezer. The neonates were bolus or con-
tinuously fed via a nasogastric feeding tube composed of
phthalate free PVC (gauge 3.5). Feeds were administered
by pouring into a sterile syringe (without plunger) that
was attached to the tube, and allowed to flow into the
stomach by gravity. Duration of feeding was less than 30
minutes. Occasionally feeds were given by continuous
infusion, and the syringe would then be changed every 4
hours.
Neonatal intensive care unit infections
During the period of sample collection, there were 38 epi-
sodes of neonatal infections in NICU 1 and 13 in NICU 2.
In NICU 1, 10 infections were due to Enterobacteriaceae; 1
E. cloacae, and 2 K. oxytoca, 3 K. pneumoniae, and 4 E. coli.
Whereas in NICU 2, 5 infections were due to Enterobacte-
riaceae; 1 E. coli, 2 K. pneumoniae, and 2 S. marcescens. The
remaining infections in both units were primarily attrib-
uted to coagulase negative staphylococci.
Microbiological analysis
Nasogastric enteral feeding tubes were collected, without
pre-selection, over a period of 11 months by nurses as part
of their routine care of neonates in intensive care. The
tubes were placed in sterile bags, and refrigerated at 5°C
until analysis (max. 24 h). The outside of the tubes were
sterilized with isopropyl alcohol. Any residual liquid in
the tube lumen was flushed into a pre-weighed sterile
Eppendorf tube, and the volume determined by weight
difference. Using aseptic techniques, the tubing was cut
into 2 cm lengths and except for the gastric 2 cm end,
placed in 5 ml sterile saline in a conical test tube. The
tubes were vortex mixed for 1 min, and then ultrasoni-
cated at 40 kHz for 5 min at room temperature. The tubes
were further vortex mixed for 1 min, and decanted into a
sterile test tube. The procedure was repeated, and the com-
bined saline rinses were centrifuged in a benchtop centri-
fuge (2400 g, 10 min). Afterwards, the supernatant was
discarded and the bacterial pellet was resuspended in 1 ml
sterile saline. The cell suspension was decimally diluted,
and 100 μl volumes were spread on Violet Red Bile Glu-
cose agar (VRBGA) plates (LabM, UK). The plates were
incubated at 37°C, for up to 48 hours. Enterobacteriaceae
colonies (red 1-2 mm diameter, usually surrounded by a
reddish zone) were counted and representative colony
types were subcultured on Tryptone Soya Agar (TSA)
plates (Merck, Germany). Isolates were initially identified
using phenotypic profiles with ID32 E (bioMerieux), and
confirmed using 16S rDNA gene sequence analysis (Accu-
genix, Delaware, USA).
Nucleotide sequence accession numbers
The GenBank accession numbers of the E. cancerogenus
and  E. hormaechei isolates sequenced in this study are
FM883655 to FM883666.
Antibiotic sensitivity testing
The susceptibilities of Enterobacteriaceae isolates to antimi-
crobial agents were determined by breakpoint on antibi-
otic supplemented Iso-Sensitest agar (catalog no.
CM0471; Oxoid Ltd.) as according to the British Society
for Antimicrobial Chemotherapy protocol [35]. The anti-
biotics tested were amikacin, gentamicin, amoxicillin,
cefotaxime, cefuroxime, ceftazidime, ciprofloxacin, amox-
icillin-clavulanic acid, gentamicin, meropenem, piperacil-
lin-tazobactam, and trimethoprim (ADATAB; Mast
Diagnostics, Bootle, United Kingdom). ESBL production
was detected using the combination disc method as
described in Health Protection Agency QSOP 51 [36]
using ceftazidime-clavulanic acid, cefotaxime clavulanic
acid, and cefpodoxime-clavulanic acid combination discs
in comparison to individual-antibiotic ceftazidime, cefo-
taxime, and cefpodoxime discs according to the manufac-
turer's instructions (Mast Diagnostics, Bootle, United
Kingdom).
Feeding regime questionnaire
During tube collection, a questionnaire concerning the
feeding regime was completed by the attendant nurse. The
feeding regime, any addition of a thickening agent, age ofBMC Infectious Diseases 2009, 9:146 http://www.biomedcentral.com/1471-2334/9/146
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neonate, duration the tube had been in place, frequency
of feeding and stomach pH prior to last feed were
recorded. The amount of information for each tube was
limited in order to comply with patient confidentiality.
No record of patient clinical condition was recorded. Con-
sequently, the source of each tube was anonymous.
Electron microscopy
The neonatal enteral feeding tube cells were fixed using
3% gluteraldehyde prepared in a 0.1 M phosphate buffer.
The tubes were cut into representative 1 cm lengths and
dissected longitudinally to expose the inner surface. The
tubes were then washed in phosphate buffer and post
fixed in 1% (w/v) osmium tetroxide prepared in 0.1 M
phosphate buffer, post fixed in 1% osmium tetroxide,
dehydrated through a gradual series of alcohol's up to
100% alcohol and then treated with hexamethyldisila-
zane for 5 minutes. The air-dried tubes were then attached
to aluminium stubs, sputter-coated with gold and exam-
ined using a Stereoscan S250 Mark III SEM at 10-20 KV.
Data analysis
The data were analysed using analysis of variance
(ANOVA) (STATISTICA software, Statsoft Inc., 2300 East
14th St, Tulsa, Ok, 74104, USA). Subsequent comparisons
between group means were made using Fisher's protected
least significant difference (PLSD) post-hoc test.
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